Amyloid Angiopathy
3
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
1 treatments under study, led by Medical Report Consultation
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (3)
ApoE Genotyping Analysis in Patients With Suspected Non-haemorrhagic Amyloid Angiopathy
Comparison of OCTA Factors in Patients With or Without Amyloid Pathology: A Prospective Study
Cerebral Infarction and White Substance in Angiopathy Cerebral Amyloid
Research Network
Common Treatments
- Medical Report Consultation1
Active Sponsors
- Pusan National University Hospital1
- Centre Hospitalier Universitaire de Nīmes1
- Fondation Hôpital Saint-Joseph1
Top Investigators
Department of Neurology, Pusan National University Hospital
Centre Hospitalier Universitaire de Nīmes
GHPSJ
Related Conditions
- Mild Cognitive Impairment1
- Dementia1
- Alzheimer Disease1
- Macular Ischemia1